COREFORT Trademark

Trademark Overview


On Thursday, March 10, 2022, a trademark application was filed for COREFORT with the United States Patent and Trademark Office. The USPTO has given the COREFORT trademark a serial number of 79338958. The federal status of this trademark filing is REGISTERED as of Tuesday, April 25, 2023. This trademark is owned by NOVARTIS AG. The COREFORT trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...

Drug delivery systems comprising infusion devices, injection devices, inhalers, polymer coatings, and bioadhesive polymers for the deferred, controlled or immediate release of active substances of pharmaceutical preparations
corefort

General Information


Serial Number79338958
Word MarkCOREFORT
Filing DateThursday, March 10, 2022
Status700 - REGISTERED
Status DateTuesday, April 25, 2023
Registration Number7033273
Registration DateTuesday, April 25, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Goods and ServicesDrug delivery systems comprising infusion devices, injection devices, inhalers, polymer coatings, and bioadhesive polymers for the deferred, controlled or immediate release of active substances of pharmaceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, October 23, 2023NOTIFICATION PROCESSED BY IB
Monday, October 2, 2023IRREGULARITY FROM IB EXAMINED BY MPU
Monday, September 18, 2023IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
Friday, August 4, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 4, 2023FINAL DISPOSITION PROCESSED
Tuesday, July 25, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 25, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 25, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 18, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 3, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, January 3, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 3, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, January 3, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 13, 2022NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Thursday, July 7, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 6, 2022NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, July 6, 2022PRIORITY ACTION E-MAILED
Wednesday, July 6, 2022PRIORITY ACTION WRITTEN
Tuesday, July 5, 2022ASSIGNED TO EXAMINER
Monday, June 20, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 20, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, June 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 20, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 10, 2022APPLICATION FILING RECEIPT MAILED
Friday, May 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 3, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 21, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB